Which hedge funds own XERS? XERIS BIOPHARMA HOLDINGS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in XERS (XERIS BIOPHARMA HOLDINGS INC) in their Q2 2026 13F filings, worth $69.4m in total. The largest holder by portfolio weight is Palogic Value Management at 0.1% of its book. 1 exited: Voss Capital.
7tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold XERS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Palogic Value Management | Q2 2026 | 0.1% | $396.5k | 50,068 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $61.8m | 7,804,758 | 0% | held |
| Citadel Advisors | Q2 2026 | 0.0% | $5.3m | 664,564 | -3% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $186.5k | 23,543 | 49% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $533.3k | 67,337 | -85% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $175.7k | 22,186 | -79% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $1.0m | 131,664 | -94% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Voss Capital | 20.8% | $8.0m |
How has hedge fund ownership of XERS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $69.4m |
| Q1 2026 | 8 | $73.9m |
| Q4 2025 | 5 | $13.8m |
| Q3 2025 | 4 | $16.1m |
| Q2 2025 | 5 | $13.0m |
| Q1 2025 | 4 | $15.1m |
| Q4 2024 | 2 | $8.1m |
| Q3 2024 | 2 | $6.0m |
| Q2 2024 | 2 | $4.3m |
| Q1 2024 | 3 | $4.2m |
| Q4 2023 | 2 | $4.5m |
| Q3 2023 | 3 | $4.3m |
| Q2 2023 | 2 | $4.5m |
| Q1 2023 | 3 | $3.2m |
| Q4 2022 | 3 | $2.0m |
| Q3 2022 | 2 | $2.4m |
Counts every tracked manager that disclosed XERS in that quarter's filing, including managers that have since stopped filing.